Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use; D017544:Aortic Aneurysm, Abdominal / Q000601:surgery; D001262:Atenolol / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D017298:Bisoprolol / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis / Q000706:statistics & numerical data; D003661:Decision Support Techniques; D006801:Humans; D007262:Infusions, Intravenous; D008790:Metoprolol / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D019990:Perioperative Care / Q000191:economics* / Q000379:methods*; D011183:Postoperative Complications / Q000191:economics; D011412:Propanolamines / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000401:mortality
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D001262:Atenolol; D008790:Metoprolol; C036604:esmolol; D017298:Bisoprolol